Please wait while your account is being registered at Tradewheel.com 
Join World's Fastest Growing B2B Network
Please wait while your account is being registered at Tradewheel.com
Join World's Fastest Growing B2B Network
| MOQ | 1200 Unit |
| Port | Singapore |
| Lead Time | 7 Days |
Having reached a landmark agreement with Gilead Sciences Inc., EVA Pharma is proud to announce that it is now a licensed manufacturer for the antiviral treatment Remdesivir in 127 countries. This game-changing development establishes EVA Pharma’s position as a global leader in the battle against COVID19-. Accordingly, it will work at ‘full capacity’ while leveraging its far-reaching network to meet the onerous challenge of alacritously providing Remdesivir to all COVID19- patients in 127 countries.
One moment please
Member's Area
Messages 
Need Help
Browse Through Millions of High-Quality Products. 